These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1227069)

  • 1. [Incidence distribution of the so-called risk factors among ovulation inhibitors].
    Ravens KG; Doré G; Jipp P
    Verh Dtsch Ges Inn Med; 1975; 81():1725-7. PubMed ID: 1227069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives--risk factors for cardiovascular events--chance association or causal relation?].
    Marmot M; Heinemann L
    Z Arztl Fortbild (Jena); 1988; 82(2):57-63. PubMed ID: 3284213
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular disease and oral contraceptives: a reappraisal of vital statistics data.
    Belsey MA; Russell Y; Kinnear K
    Fam Plann Perspect; 1979; 11(2):84-9. PubMed ID: 456491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advantages and disadvantages of hormonal pregnancy regulation (so-called ovulation inhibitors)].
    Hauser GA
    Ther Umsch; 1968 Jun; 25(6):332-7. PubMed ID: 5733262
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver tumors and ovulation inhibitors].
    Arnold W
    Dtsch Med Wochenschr; 1991 Jun; 116(23):917. PubMed ID: 2040212
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular issues with oral contraceptives: evidenced-based medicine.
    Burkman RT
    Int J Fertil Womens Med; 2000; 45(2):166-74. PubMed ID: 10831186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives and cardiovascular diseases].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Mar; 54():63-6. PubMed ID: 3721247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular complications, lipoprotein metabolism and oral contraceptives].
    Gagné C
    Union Med Can; 1985 Oct; 114(10):865-71. PubMed ID: 4082353
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptive hazards--1981.
    Goldzieher JW
    Tex Med; 1981 Nov; 77(11):61-4. PubMed ID: 7323970
    [No Abstract]   [Full Text] [Related]  

  • 10. [On ovulation inhibitors].
    Heinen G
    Hippokrates; 1967 Jan; 38(2):53-60. PubMed ID: 6063183
    [No Abstract]   [Full Text] [Related]  

  • 11. The Transnational study of oral contraceptive cardiovascular safety: history and science.
    Suissa S
    J Clin Epidemiol; 2009 Jun; 62(6):588-93. PubMed ID: 19345559
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies with ovulation inhibitors for the demonstration of direct and indirect effects on the portio and vagina].
    Bayer R
    Zentralbl Gynakol; 1968 Apr; 90(16):552-9. PubMed ID: 5662449
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ovulation inhibitors in the treatment of skin diseases.
    Vánkos J
    Ther Hung; 1970; 18(1):33-9. PubMed ID: 4246438
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality among oral contraceptive users.
    Porter JB; Jick H; Walker AM
    Obstet Gynecol; 1987 Jul; 70(1):29-32. PubMed ID: 3601267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
    Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Against continuing oral contraceptives up to age 50].
    Haramburu F
    Gynecol Obstet Fertil; 2005 Mar; 33(3):166-8. PubMed ID: 15848093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.